Argenx
ARGX
#405
Rank
โ‚น5.899 T
Marketcap
โ‚น94,860
Share price
-0.55%
Change (1 day)
45.50%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: โ‚น5.899 Trillion

As of September 2026 Argenx has a market cap of โ‚น5.899 Trillion. This makes Argenx the world's 405th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น5.899 T24.89%
2025โ‚น4.723 T47.02%
2024โ‚น3.212 T71.02%
2023โ‚น1.878 T8.32%
2022โ‚น1.734 T26.7%
2021โ‚น1.368 T33.48%
2020โ‚น1.025 T109.06%
2019โ‚น490.51 B100.08%
2018โ‚น245.15 B91.51%
2017โ‚น128.01 B
2014โ‚น9.22 B

End of Day market cap according to different sources

On Sep 20th, 2026 the market cap of Argenx was reported to be:

โ‚น5.887 Trillion
by Nasdaq info icon info icon
โ‚น5.899 Trillion
by CompaniesMarketCap info icon info icon